Who Owns Senti Biosciences Stock?
NASDAQ: SNTIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 9:35 AM ET
Ownership breakdown
- Held by institutions
- 19.03%
- Held by insiders
- 48.43%
- Institutional holders
- 23
- Institutions 19.0%
- Insiders 48.4%
- Public and other 32.5%
Who owns Senti Biosciences stock?
Institutional investors own about 19.0% of Senti Biosciences's shares, spread across 23 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 48.43% of SNTI.
The largest institutional holders are Nantahala Capital Management, LLC (2.85%), Vanguard Capital Management LLC (1.73%) and Geode Capital Management, LLC (0.60%). Together, the top 10 institutions control 6.3% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their SNTI positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SNTI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Nantahala Capital Management, LLC | 888.00K | 2.85% | +100.0% |
| Vanguard Capital Management LLC | 537.50K | 1.73% | +100.0% |
| Geode Capital Management, LLC | 187.06K | 0.60% | +100.0% |
| Citadel Advisors Llc | 107.10K | 0.34% | +100.0% |
| Vanguard Fiduciary Trust Co | 91.19K | 0.29% | +100.0% |
| Jane Street Group, LLC | 52.53K | 0.17% | +100.0% |
| Menlo Ventures Management, L.P. | 35.74K | 0.11% | +100.0% |
| Northern Trust Corporation | 32.15K | 0.10% | +100.0% |
| Xtx Topco Ltd | 23.61K | 0.08% | +100.0% |
| Virtu Financial LLC | 22.80K | 0.07% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SNTI
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 368.88K | 1.18% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 168.63K | 0.54% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 95.55K | 0.31% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 24.80K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 19.99K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 18.80K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Senti Biosciences?
Nantahala Capital Management, LLC is the largest institutional shareholder of SNTI, owning 2.85% of shares outstanding (888.00K shares) as of its latest 13F filing.
What percentage of Senti Biosciences is owned by institutions?
Institutions own about 19.0% of SNTI shares and 36.9% of the public float.
How much of Senti Biosciences do insiders own?
Insiders, such as officers and directors, own about 48.43% of SNTI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.